Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Wiley Interdiscip Rev Syst Biol Med. 2013 Jan-Feb;5(1):73-82. doi: 10.1002/wsbm.1198. Epub 2012 Nov 26.
The rapid development of high-throughput technologies and computational frameworks enables the examination of biological systems in unprecedented detail. The ability to study biological phenomena at omics levels in turn is expected to lead to significant advances in personalized and precision medicine. Patients can be treated according to their own molecular characteristics. Individual omes as well as the integrated profiles of multiple omes, such as the genome, the epigenome, the transcriptome, the proteome, the metabolome, the antibodyome, and other omics information are expected to be valuable for health monitoring, preventative measures, and precision medicine. Moreover, omics technologies have the potential to transform medicine from traditional symptom-oriented diagnosis and treatment of diseases toward disease prevention and early diagnostics. We discuss here the advances and challenges in systems biology-powered personalized medicine at its current stage, as well as a prospective view of future personalized health care at the end of this review.
高通量技术和计算框架的快速发展使人们能够以前所未有的细节研究生物系统。反过来,在组学水平上研究生物现象有望推动个性化和精准医疗的重大进展。可以根据患者自身的分子特征进行治疗。个体的组学特征以及多个组学特征的综合特征,如基因组、表观基因组、转录组、蛋白质组、代谢组、抗体组和其他组学信息,有望用于健康监测、预防措施和精准医疗。此外,组学技术有可能将医学从传统的以症状为导向的疾病诊断和治疗转变为疾病预防和早期诊断。在这篇综述的结尾,我们讨论了当前阶段基于系统生物学的个性化医学的进展和挑战,以及对未来个性化医疗保健的展望。